Zobrazeno 1 - 7
of 7
pro vyhledávání: '"64"'
Autor:
D. Zips, D.G. Bosetti, M. Pinkawa, Marcin Sumila, V. Budach, Davide G. Bosetti, P.M. Putora, G. Pesce, George N. Thalmann, Daniel M. Aebersold, Kaouthar Khanfir, Jürg Bernhard, Bülent Polat, F. Zimmermann, S. Gomez, Piet Ost, K. Berkovic, F. Behrensmeier, P. Wust, L. Plasswilm, J. Collon, P. Messer, S. Bodis, M. Baumann, Silvia Gomez, M. Sumila, V. Lewitzki, M. Sassowsky, H. Kranzbühler, Kathrin Zaugg, Peter Wust, D.M. Aebersold, P. Thum, M. Guckenberger, Matthias Guckenberger, Y. Najafi, S. Wuttke, C. Belka, D.R. Zwahlen, Guido Hildebrandt, Pirus Ghadjar, A. Papachristofilou, Philipp Gut, Corinne Schär, G.N. Thalmann, F. Vandaele, K. Beer, P. Ost, M. Stuschke, M. Flentje, A. Müller, C. Reuter, P. Ghadjar, C. Oehler, Christiane Reuter, Daniel R. Zwahlen, I. Tacacs, Arndt-Christian Müller, M. Brown, K. Khanfir, G. Hildebrandt, Ludwig Plasswilm, T. Hölscher, N.C. Azinwi, Tobias Hölscher, M.J. Eble, U. Ganswindt, Stefanie Hayoz, P. Gut, Alexandros Papachristofilou, B. Polat, K. Zaugg
Publikováno v:
European Urology. 80:306-315
Background Salvage radiotherapy (SRT) is utilized for biochemical progression of prostate cancer after radical prostatectomy (RP). Objective To report the outcomes of the SAKK 09/10 trial comparing conventional and dose-intensified SRT. Design, setti
Autor:
Philip, van Kerrebroeck, Christopher, Chapple, Ted, Drogendijk, Monique, Klaver, Roman, Sokol, Mark, Speakman, Klaudia, Traudtner, Marcus J, Drake, J, MacDermott
Publikováno v:
European urology, 64(6), 1003-1012. Elsevier
European Urology, 64(6), 1003-1012. Elsevier
European Urology, 64(6), 1003-1012. Elsevier
Background Storage symptoms are particularly bothersome in men with lower urinary tract symptoms (LUTS) but may not be adequately treated by α-blocker monotherapy. Objective To assess the efficacy and safety of a fixed-dose combination (FDC) of soli
Autor:
Fernando Calais da Silva, Linhares Furtado, Mário Reis, Fernando Carreira, Vitor Dias, Gomes Oliveira, null Members of the Portuguese Genito-Urinary Group
Publikováno v:
European Urology. 28:219-296
The purpose of the study was to compare two doses of interferon-α 2b (60 and 100 million units, MU) and to define the recurrence rate per year, tumor rate per year and the toxicity for both treatment arms. 127 patients were admitted to the study and
Autor:
Alberto Garcia-Hernandez, Klaudia Traudtner, Ferenc Katona, Philip Van Kerrebroeck, Matthias Oelke, Monique Klaver, François Haab, Javier C. Angulo, Viktor Vik
Publikováno v:
European Urology, 64(3), 398-407. Elsevier
Background Storage symptoms are often undertreated in men with lower urinary tract symptoms (LUTS). Objective To evaluate the combination of an antimuscarinic (solifenacin) with an α-blocker (tamsulosin) versus tamsulosin alone in the treatment of m
Autor:
Dominique Chopin, Fabien Saint, Philippe Sebe, Aristotelis G. Anastasiadis, Laurent Salomon, Clément-Claude Abbou
Publikováno v:
European Urology. 44:656-660
Introduction: The results of radical prostatectomy (cancer control, continence and sexual potency) are currently presented separately, while the success of this surgery depends on a combination of good cancer control with maintenance of continence an
Publikováno v:
European urology, vol 68, iss 4
Punnen, S; Cowan, JE; Chan, JM; Carroll, PR; & Cooperberg, MR. (2015). Long-term health-related quality of life after primary treatment for localized prostate cancer: Results from the CaPSURE registry. European Urology, 68(4), 600-608. doi: 10.1016/j.eururo.2014.08.074. UCSF: Retrieved from: http://www.escholarship.org/uc/item/9r15370t
Punnen, S; Cowan, JE; Chan, JM; Carroll, PR; & Cooperberg, MR. (2015). Long-term health-related quality of life after primary treatment for localized prostate cancer: Results from the CaPSURE registry. European Urology, 68(4), 600-608. doi: 10.1016/j.eururo.2014.08.074. UCSF: Retrieved from: http://www.escholarship.org/uc/item/9r15370t
© 2014 European Association of Urology. Background Few studies have reported on late declines and long-term health-related quality of life (HRQOL) after prostate cancer (PCa) treatment. Objective We assessed long-term HRQOL following various treatme
Publikováno v:
European urology. 42(4)
In this prospective study our aim was to establish the time it takes cystectomized patients' to adapt to their new health status.A total of 68 patients, having radical cystectomy for bladder cancer (64 males and 4 females) were enrolled in the study.